-- iX Biopharma (SGX:42C) received a listing and quotation notice from the Singapore Exchange Securities Trading for 1.3 million shares, according to a Thursday filing with the Singapore Exchange.
Shares of the pharmaceutical and nutraceutical company surged nearly 11% in Monday trading.
The notice is subject to shareholder approval and compliance with the bourse's listing requirements, the filing added.